HolmesA. Staphylococcus aureus carrying Panton-Valentine Leukocidin genes (PVL) in England and Wales: frequency, characterisation and association with clinical disease. J Clin Micro2005; 43: 2384–2390.
2.
ReichertBBirrellG. Severe non-pneumonic necrotising infections in children caused by Panton-Valentine Leukocidin producing Staphylococcus aureus strains. J Infection2005; 50: 438–442.
3.
GilletY. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet2002; 359: 753–759.
4.
KleinJL. Severe community-acquired pneumonia caused by Panton-Valentine Leukocidin-positive Staphylococcus aureus: first reported case in the United Kingdom. Int Care Med2003; 29: 1399.
5.
FrancisJS. Severe community-onset pneumonia in healthy adults caused by methicillin - resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis2005; 40: 100–7.
6.
WargoKAEilandEH. Appropriate therapy for community acquired methicillin resistant Staphylococcus aureus carrying the Panton Valentine leukocidin gene. Clin Infect Dis2005; 40: 1376–7.
7.
MicekATDunneMKollefMH. Pleuropulmonary complications and Panton-Valentine Leucocidin -Positive Community -Acquired Methicillin-Resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest2005; 128: 2732–2738.
8.
Norrby-TeglundA. Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive Group A streptococcal infections. Scand J Infect Dis2003; 35: 683–689.
9.
DarenbergJ. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications and therapy of toxic shock syndrome. Clin Infect Dis2004; 38: 826–42.